Prevalence of osteoporosis in China: a meta-analysis and systematic review-Reference-Cited by-同舟云学术

Prevalence of osteoporosis in China: a meta-analysis and systematic review

Published:2016-10-03 Issue:1 Volume:16 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Chen Peng,Li Zhanzhan,Hu Yihe

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s12889-016-3712-7.pdf

Reference31 articles.

1. Leslie WD, Morin SN. Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol. 2014;26(4):440–6.

2. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1–129.

3. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243–51.

4. Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos. 2014;9:182.

5. US OOTS. Bone health and osteoporosis: a report of the surgeon general. Rockville: Office of the Surgeon General (US); 2004.

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood bone mineral density: A prospective birth cohort study;International Journal of Hygiene and Environmental Health;2025-01

2. Associations between gut microbiota and osteoporosis or osteopenia in a cohort of Chinese Han youth;Scientific Reports;2024-09-09

3. An intelligent controlled release hydrogel with photothermal effect for the treatment of bone defects;Chemical Engineering Journal;2024-09

4. Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis;Journal of Orthopaedic Surgery and Research;2024-08-29

5. Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis;Frontiers in Medicine;2024-08-14